A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients

NCT03047837 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

160

Enrollment

OTHER

Sponsor class

Stopped lack of enrolment

Conditions

Tertiary Prevention in Colon Cancer

Interventions

DRUG: ASA
DRUG: MET
OTHER: Placebo

Sponsor

Ente Ospedaliero Ospedali Galliera